Drug makers have promised to keep a minimum buffer stock of 100 million tablets of chloroquine tablets and HCQ India’s pharmaceutical industry has assured the government it will be able to comfortably meet the domestic needs for hydroxychloroquine after exporting to the US and other overseas buyers, industry executives said.
The malaria drug is touted by some—most famously US President Donald Trump—as a potential cure for covid-19, although there is only anecdotal evidence for it.
Putting at rest fears that India could run short of the drug, pharmaceutical firms have promised that they will keep a minimum buffer stock of 100 million tablets of chloroquine and its safer derivative hydroxychloroquine before exporting any. “Production is